Artiva Biotherapeutics, Inc.
ARTV
$3.64
$0.061.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 122.97M | 142.37M | 165.96M | 185.43M | 146.63M |
| Total Receivables | 879.00K | 1.03M | 234.00K | 1.19M | 1.40M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.68M | 5.67M | 3.81M | 5.21M | 2.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 129.52M | 149.07M | 170.00M | 188.63M | 150.57M |
|
|
|||||
| Total Current Assets | 129.52M | 149.07M | 170.00M | 188.63M | 150.57M |
| Net Property, Plant & Equipment | 18.46M | 19.83M | 20.79M | 20.43M | 21.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 879.00K | 499.00K | 474.00K | 525.00K | 556.00K |
| Total Assets | 148.86M | 169.39M | 191.26M | 209.58M | 225.60M |
|
|
|||||
| Total Accounts Payable | 848.00K | 1.22M | 2.04M | 1.12M | 1.22M |
| Total Accrued Expenses | 7.03M | 5.84M | 6.38M | 7.39M | 8.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.17M | 3.64M | 3.72M | 3.74M | 3.73M |
| Total Finance Division Other Current Liabilities | 73.00K | 73.00K | 73.00K | -- | -- |
| Total Other Current Liabilities | 73.00K | 73.00K | 73.00K | -- | -- |
| Total Current Liabilities | 11.12M | 10.77M | 12.20M | 12.25M | 13.29M |
|
|
|||||
| Total Current Liabilities | 11.12M | 10.77M | 12.20M | 12.25M | 13.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.52M | 9.58M | 10.28M | 10.61M | 11.24M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 73.00K | 73.00K |
| Total Liabilities | 19.64M | 20.35M | 22.48M | 22.94M | 24.60M |
|
|
|||||
| Common Stock & APIC | 438.91M | 437.29M | 435.78M | 433.45M | 431.25M |
| Retained Earnings | -309.78M | -288.25M | -267.00M | -246.68M | -230.59M |
| Treasury Stock & Other | 87.00K | 2.00K | -- | -129.00K | 338.00K |
| Total Common Equity | 129.22M | 149.04M | 168.78M | 186.64M | 201.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 129.22M | 149.04M | 168.78M | 186.64M | 201.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 129.22M | 149.04M | 168.78M | 186.64M | 201.00M |
|
|
|||||